Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures

Epilepsy and Behavior

Volumn 23, Issue 3, 2012, Pages 230-234

  Borghs, Simon ^a   de la Loge, Christine ^a   Cramer, Joyce A ^b  

^a UCB PHARMA   (Belgium)

^b YALE UNIVERSITY   (United States)

Author keywords

Epilepsy; MIC; Minimally important change; QOLIE 31; Quality of life

Indexed keywords

HARKOSERIDE; PLACEBO;

ARTICLE; DRUG EFFECT; ENERGY; FATIGUE; FOCAL EPILEPSY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUALITY OF LIFE INVENTORY IN EPILEPSY; SCORING SYSTEM; SOCIAL INTERACTION; TREATMENT OUTCOME;

ACETAMIDES; ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; MULTICENTER STUDIES AS TOPIC; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858279624     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.12.023     Document Type: Article

References (17)

1. Cramer J.A., Perrine K., Devinsky O., Bryant-Comstock L., Meador K., Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998, 39:81-88.
2. Vickrey B., Perrine K., Hays R., Hermann B.P., Cramer J.A., Meador K.J., Devinsky O. Quality of life in epilepsy QOLIE-31 (version 1.0): scoring manual and patient inventory 1993, RAND, Santa Monica, CA.
3. Cramer J.A., Hammer A.E., Kustra R.P. Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy Behav 2004, 5:224-230.
4. Crosby R.D., Kolotkin R.L., Williams G.R. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003, 56:395-407.
5. Wiebe S., Eliasziw M., Matijevic S. Changes in quality of life in epilepsy: how large must they be to be real?. Epilepsia 2001, 42:113-118.
6. Wiebe S., Matijevic S., Eliasziw M., Derry P.A. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry 2002, 73:116-120.
7. Chassany O., Marquis P., Fullerton S., Aaronson N. Patient-reported outcomes: the example of health-related quality of life-a European guidance for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 2002, 209-238.
8. Ben-Menachem E., Biton V., Jatuzis D., Abou-Khalil B., Doty P., Rudd G.D. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007, 48:1308-1317.
9. Chung S., Sperling M.R., Biton V., Krauss G., Hebert D., Rudd G.D., Doty P., on behalf of the SP754 Study Group Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 2010, 51(6):958-967.
10. Halasz P., Kalviainen R., Mazurkiewicz-Beldzinska M., Doty P., Hebert D., Sullivan T. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009, 50:443-453. on behalf of the SP755 Study Group.
11. Devinsky O., Vickrey B.G., Cramer J., Perrine K., Hermann B., Meador K., Hays R.D. Development of the quality of life in epilepsy inventory. Epilepsia 1995, 36:1089-1104.
12. Brozek J.L., Guyatt G.H., Schunemann H.J. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health Qual Life Outcomes 2006, 4:69.
13. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Erlbaum Associates, Hillsdale, NJ. 2nd ed.
14. Wyrwich K.W., Nienaber N.A., Tierney W.M., Wolinsky F.D. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999, 37:469-478.
15. Jacobson N.S., Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991, 59:12-19.
16. Lydick E., Epstein R.S. Interpretation of quality of life changes. Qual Life Res 1993, 2:221-226.
17. Bohning D., Bohning W., Holling H. Revisiting Youden's index as a useful measure of the misclassification error in meta-analysis of diagnostic studies. Stat Methods Med Res 2008, 17:543-554.